United Capital Financial Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15,124
| Closed | -$1.11M | – | 1032 |
|
|
2022
Q4 | $1.11M | Buy |
15,124
+7,126
| +89% | +$523K | 0.01% | 585 |
|
|
2022
Q3 | $608K | Sell |
7,998
-74
| -0.9% | -$5.63K | ﹤0.01% | 724 |
|
|
2022
Q2 | $561K | Buy |
8,072
+172
| +2% | +$12K | ﹤0.01% | 769 |
|
|
2022
Q1 | $655K | Buy |
7,900
+425
| +6% | +$35.2K | ﹤0.01% | 772 |
|
|
2021
Q4 | $561K | Hold |
7,475
| – | – | ﹤0.01% | 827 |
|
|
2021
Q3 | $868K | Sell |
7,475
-5
| -0.1% | -$581 | ﹤0.01% | 711 |
|
|
2021
Q2 | $1.66M | Buy |
7,480
+4
| +0.1% | +$887 | 0.01% | 580 |
|
|
2021
Q1 | $988K | Sell |
7,476
-11
| -0.1% | -$1.45K | 0.01% | 675 |
|
|
2020
Q4 | $1.3M | Buy |
7,487
+18
| +0.2% | +$3.12K | 0.01% | 608 |
|
|
2020
Q3 | $831K | Sell |
7,469
-600
| -7% | -$66.8K | 0.01% | 701 |
|
|
2020
Q2 | $478K | Buy |
8,069
+600
| +8% | +$35.5K | ﹤0.01% | 874 |
|
|
2020
Q1 | $503K | Buy |
7,469
+11
| +0.1% | +$741 | ﹤0.01% | 807 |
|
|
2019
Q4 | $628K | Hold |
7,458
| – | – | ﹤0.01% | 919 |
|
|
2019
Q3 | $558K | Buy |
7,458
+59
| +0.8% | +$4.41K | ﹤0.01% | 916 |
|
|
2019
Q2 | $468K | Buy |
7,399
+87
| +1% | +$5.5K | ﹤0.01% | 1059 |
|
|
2019
Q1 | $352K | Hold |
7,312
| – | – | ﹤0.01% | 1068 |
|
|
2018
Q4 | $245K | Sell |
7,312
-1,263
| -15% | -$42.3K | ﹤0.01% | 1137 |
|
|
2018
Q3 | $449K | Buy |
8,575
+263
| +3% | +$13.8K | ﹤0.01% | 993 |
|
|
2018
Q2 | $260K | Buy |
+8,312
| New | +$260K | ﹤0.01% | 1138 |
|